Current role of allogeneic stem cell transplantation in follicular lymphoma.
Farina
Lucia
L
Corradini
Paolo
P
D000970:Antineoplastic Agents / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D015331:Cohort Studies; D003131:Combined Modality Therapy; D019008:Drug Resistance, Neoplasm; D020350:Graft vs Tumor Effect; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000627:therapeutic use; D008212:Lymphocyte Depletion; D017710:Lymphocyte Transfusion; D008224:Lymphoma, Follicular / Q000188:drug therapy / Q000473:pathology / Q000601:surgery*; D009381:Neoplasms, Radiation-Induced / Q000209:etiology; D016609:Neoplasms, Second Primary / Q000209:etiology; D036102:Peripheral Blood Stem Cell Transplantation; D015996:Survival Rate; D013601:T-Lymphocytes; D019172:Transplantation Conditioning / Q000009:adverse effects / Q000379:methods*; D014182:Transplantation, Autologous; D014184:Transplantation, Homologous; D014916:Whole-Body Irradiation / Q000009:adverse effects
D000970:Antineoplastic Agents; D007166:Immunosuppressive Agents